Daniel ShinYu Chen - 01 Jul 2021 Form 4 Insider Report for IGM Biosciences, Inc. (IGMS)

Role: Chief Medical Officer
Signature: /s/ Misbah Tahir, by power of attorney
Issuer symbol: IGMS
Transactions as of: 01 Jul 2021
Net transactions value: -$160,977
Form type: 4
Filing time: 06 Jul 2021, 19:45:18 UTC
Previous filing: 03 Jun 2021
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	IGMS	Common Stock	Options Exercise	$2,641	+1,900	+1.6%	$1.39^*	118,418	01 Jul 2021	Direct	F1
transaction	IGMS	Common Stock	Tax liability	$85,585	-957	-0.81%	$89.43	117,461	01 Jul 2021	Direct	F2
transaction	IGMS	Common Stock	Sale	$78,033	-943	-0.8%	$82.75	116,518	06 Jul 2021	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	IGMS	Stock Option (right to buy)	Options Exercise	$0	-1,900	-0.56%	$0.000000	338,340	01 Jul 2021	Common Stock	1,900	$1.39	Direct	F1, F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The option exercise and sale were effected pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person.
F2	Represents shares withheld by the Issuer to pay the exercise price and taxes pursuant to the "net exercise" of 1,900 option shares.
F3	The option, originally for 361,090 shares, of which 22,750 shares have been exercised, vested as to 1/4 of the shares on August 1, 2019, and an additional 1/48 of the shares subject to the option shall vest monthly thereafter, subject to the Reporting Person remaining a service provider through each such date.